|
Author: C. Beyer, N. Reich, S. Schindler, et al
Date Published: January-2012 Source: Annals of the Rheumatic Diseases
Fibrosis and vascular disease are cardinal features of systemic sclerosis (SSc). Stimulators of soluble guanylate cyclase (sGC) are vasoactive drugs that are currently being evaluated in phase III clinical trials for pulmonary arterial hypertension.
|